Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)
Clinical trial NCT05938465 · RECRUITING
Trial details
- NCT number
- NCT05938465
- Sponsor
- Exegi Pharma, LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-06
- Primary completion
- 2027-05-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.